Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19538
Submission : 2006-06-20
Status : Active
Type : IV
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37676
Submission : 2022-11-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18881
Submission : 2005-10-15
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36348
Submission : 2021-11-03
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16697
Submission : 2003-07-09
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14975
Submission : 2000-07-31
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11797
Submission : 1995-10-27
Status : Inactive
Type : IV

NDC Package Code : 51552-1414
Start Marketing Date : 2012-04-01
End Marketing Date : 2027-04-15
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

NDC Package Code : 51552-1527
Start Marketing Date : 2016-09-15
End Marketing Date : 2027-07-07
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FINISHED DOSAGE FORMULATIONS
Drug : CABLIVI
Dosage Form : INJECTABLE; INJECTION
Application Number : 761112
Country : US
Patented : No
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Drug : RIFATER
Dosage Form : TABLET; ORAL
Application Number : 50705
Country : US
Patented : No
Drug : CLOMID
Dosage Form : TABLET; ORAL
Application Number : 16131
Country : US
Patented : No
Drug : CANTIL
Dosage Form : SOLUTION; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : CANTIL
Dosage Form : TABLET; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : TRICOR
Dosage Form : TABLET; ORAL
Application Number : 21656
Country : US
Patented : No
Drug : SYNTHROID
Dosage Form : TABLET; ORAL
Application Number : 21402
Country : US
Patented : No
Drug : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204168
Country : US
Patented : Yes
Drug : DEPAKENE
Dosage Form : SYRUP; ORAL
Application Number : 18082
Country : US
Patented : No
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 22.26
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 85.46
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 182.4
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 527.43
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 17.6
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 1195.44
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 166
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 2323.3
Potency Unit : MG/1PKT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
23 Aug 2025
Reply
02 Aug 2025
Reply
21 May 2025
Reply
14 Apr 2025
Reply
16 Jun 2023
Reply
28 Jun 2022
Reply
22 Feb 2022
Reply
07 Sep 2021
Reply
24 Jun 2021
Reply
03 Sep 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number : 73264-44-5
Quantity Per Vial :
Sale Unit :
Price : $184.00
Details :
Monograph : PHR2792-500MG
Storage : -10°C to -25°C
Code/Batch No :
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $116.00
Details :
Monograph : PHR1001-1G
Storage : +2?C to +30?C
Code/Batch No :

CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $184.00
Details :
Monograph : PHR2792-500MG
Storage : -10?C to -25?C
Code/Batch No :

Sucrose Diacetate Hexaisobutyrate (1 mL)
CAS Number : 126-13-6
Quantity Per Vial : 1
Sale Unit : ml
Price : $305.00
Details : Material Origin- Chemical Synthesis; USMCA- Y...
Monograph :
Storage :
Code/Batch No : Catalog #1623580 / F12030

CAS Number : 126-14-7
Quantity Per Vial : 500
Sale Unit : mg
Price : $265.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1623615 / F0G032

CAS Number : 57-50-1
Quantity Per Vial : 100
Sale Unit : mg
Price : $275.00
Details : Material Origin- Plant; USMCA- No; KORUS- No
Monograph :
Storage :
Code/Batch No : Catalog #1623637 / R04311

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]